These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 10206574
1. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Guy J, Aptsiauri N. Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574 [Abstract] [Full Text] [Related]
2. Cancer-associated retinopathy associated with invasive thymoma. Katsuta H, Okada M, Nakauchi T, Takahashi Y, Yamao S, Uchida S. Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250 [Abstract] [Full Text] [Related]
3. [Paraneoplastic retinopathy in 2 patients with breast carcinoma]. Huober J, Holz FG, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G. Zentralbl Gynakol; 1997 Sep; 119(6):278-81. PubMed ID: 9312964 [Abstract] [Full Text] [Related]
4. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G. Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281 [Abstract] [Full Text] [Related]
5. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Potter MJ, Thirkill CE, Dam OM, Lee AS, Milam AH. Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347 [Abstract] [Full Text] [Related]
6. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA. Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357 [Abstract] [Full Text] [Related]
7. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I. Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517 [Abstract] [Full Text] [Related]
8. Autoimmune retinopathy in the absence of cancer. Mizener JB, Kimura AE, Adamus G, Thirkill CE, Goeken JA, Kardon RH. Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066 [Abstract] [Full Text] [Related]
9. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204 [Abstract] [Full Text] [Related]
10. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Bazhin AV, Shifrina ON, Savchenko MS, Tikhomirova NK, Goncharskaia MA, Gorbunova VA, Senin II, Chuchalin AG, Philippov PP. Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119 [Abstract] [Full Text] [Related]
11. [Carcinoma-associated retinopathy: a review with clinical examples]. Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E. Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938 [Abstract] [Full Text] [Related]
12. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Lei B, Bush RA, Milam AH, Sieving PA. Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629 [Abstract] [Full Text] [Related]